Abstract
Fifty-five episodes of Pneumocystis carinii pneumonia (PCP) in AIDS patients were evaluated to assess clinical and laboratory risk factors predicting the probability of surviving the acute episode of PCP and the long-term survival after PCP. Age > 45 yrs, PaO2 < 50 mmHg, AaPO2 > 50 mmHg, and LDH > 800 IU/L correlated strongly with early mortality; patients who needed mechanical ventilation had a significantly lower PaO2 and serum albumin, and higher AaPO2 and LDH compared to the patients who did not. Neither age nor PaO2, AaPO2, LDH, albumin, days from onset, time for recovery, CD4+ cell count correlated with long-term survival of AIDS patients with PCP. Informations obtained at initial presentation of PCP may predict early outcome and influence therapeutic approach, improving chances for survival.
Similar content being viewed by others
References
AllegraC.J., ChabnerB.A., TuazonC.U., OgataArakakiD., BairdB., DrakeJ.C., SimmonsT., LackE.E., ShelhamerJ.H., BalisF., WalkerR., KovacsJ.A., LaneH.C. and MasurH. (1987): Trimetrexate for the treatment of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome - N. Engl. J. Med. 317: 878–985.
ArmitageP. and BerryG. (1987): Statistical methods in medical research - Blackwell Scientific Publication, Oxford.
BozzetteS.A., SattlerF.R., ChiuJ., WuA.W., GlucksteinD., KemperC., BartokA., NiosiJ., AbramsonI., CoffmanJ., HughlettC, LoyaR., CassensB., AkilB., MengT-C., BoylenC.T., NielsenD., RichmanD.D., TillesJ.G., LeedomJ., McCutchanJ.A. and The California Collaborative Treatment Group (1990): A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome - N. Engl. J. Med. 323: 1451–1457.
BrennerM., OgnibeneF.R., LackE.E., SimmonsJ.T., Suffredini A.F., LaneH.C., FauciA.S., ParrilloJ.E., ShelhamerJ.H. and MasurH. (1987): Prognostic factors and life expectancy of patients with acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia - Am. Rev. Respir. Dis. 136:1199–1206.
Centers for Disease Control (1989): Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons with human immunodeficiency virus infection - M.M.W.R. 38: 1–9.
El-SadrW. and SimberkoffM.S. (1988): Survival and prognostic factors in severe Pneumocystis carinii pneumonia requiring mechanical ventilation - Am. Rev. Respir. Dis. 137: 1264–1267.
FischlM.A., RichmanD.D., GriecoM.H., et al. (1987): The efficacy of azidothymydine (AZT) in the treatment of patients with AIDS and AIDS-related complex - N. Engl. J. Med. 317: 185–191.
FriedmanY., FranklinC., RackowE.C. and WeilM.H. (1991): Improved survival in patients with AIDS, Pneumocystis carinii pneumonia, and severe respiratory failure - Chest 96: 862–866.
GagnonS., BootaA.M., FischlM.A., BaierH., KirkseyO.W. and LaVoieL. (1990): Cortocosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A double blind, placebo-controlled trial -N. Engl. J. Med. 323: 1444–1450.
GarayS.M. and GrenJ (1989): Prognostic indicators in the initial presentation of Pneumocystis carinii pneumonia - Chest 95: 769–772.
GordinF.M., SimeonG.L., WofsyCB. and MillsJ. (1984): Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome - Ann. Intern. Med. 100: 495–499.
HarrisJ.E. (1990): Improved short-term survival of AIDS patients initially diagnosed with Pneumocystis carinii pneumonia 1984 though 1989 - J.A.M.A. 263: 397–401.
KalesC.P., MurrenJ.R., TorresR.A. and CroccoJ.A. (1987): Early predictors of in-hospital mortality for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome - Arch. Intern. Med. 147: 1413–1417.
KaplanE.L. and MeyerP. (1958): Non-parametric estimation from incomplete observations - J. Am. Stat. Assoc. 53: 175–181.
KatzM.H., BaronR.B. and GradyD. (1991): Risk stratification of ambulatory patients suspected of Pneumocystis pneumonia - Arch. Intern. Med. 151: 105–110.
KovacsJ.A., HiemenzJ.W., MacherA.M., StoverD., MurrayH.W., ShelhamerJ., LaneH.C., UrmacherC., HoningC., LongoD.L., ParkerM.M., NatansonC., ParrilloJ.E., FauciA.S., PizzoP.A. and MasurH. (1984): Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies - Ann. Intern. Med. 100: 663–671.
LeoungG.S., FeigalD.W., MontgomeryA.B., CorkeryK., WardlawL., AdamsM., BuschD., GordonS., JacobsonM.A., VolberdingP.A., AbramsD. and The San Francisco Country Community Consortium (1990): Aerosolised pentamidine for prophylaxis against Pneumocystis carinii pneumonia. The San Francisco Community Prophylaxis Trial - N. Engl. J. Med. 323: 769–775.
MasonG.R., HashimotoC.H., DickmanP.S., Foutty itL.F. and CobbJ.C. (1989): Prognostic implications of bronchoalveolar lavage neutrophilia in patients with Pneumocystis carinii pneumonia and AIDS - Am. Rev. Respir. Dis. 139: 1336–1342.
OgnibeneF.P.ShelhamerJ., GillV., et al. (1984): The diagnosis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome using subsegmental bronchoalveolar lavage - Am. Rev. Respir. Dis. 129: 929–932.
PetersB.S., BeckE.J., ColemanD.G., WadsworthM.J.H., McGuinnes0., HarrisJ.R.W. and PinchingA.J. (1991): Changing disease patterns in patients with AIDS in a referral centre in the United Kingdom: the changing face of AIDS - Br. Med. J. 302: 203–207.
PhairJ., MunozA., DetelsR., KaslowR., RinaldoC., SaahA. and The Multicenter AIDS Cohort Study Group (1990): The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1 - N. Engl. J. Med. 322: 161–165.
SelikR.M., StarcherE.T. and CurranJ.W. (1987): Opportunistic diseases reported in AIDS patients: frequency, associations and trends - AIDS 1: 175–182.
ShelhamerJ.H., OgnibeneF.P., MacherA.M., et al. (1984): Persistence of Pneumocystis carinii in lung tissue of acquired immunodeficiency syndrome patients treated for pneumocystis pneumonia - Am. Rev. Respir. Dis. 130: 1611–1665.
SimonR. (1986): Confidence intervals for eparting of clinical trials - Ann. Intern. Med. 105: 429–435.
SmithR.L., El-SadrW.M. and LewisM.L. (1988): Correlation of bronchoalveolar lavage cell population with clinical severity of Pneumocystis carinii pneumonia - Chest 93: 60–64.
SpeichR., WeberR., KronauerC.M., OpravilM., LuthyR. and RussiE.W. (1990): Prognostic score for Pneumocystis carinii pneumonia - Respiration 57: 259–263.
WatcherR.M., LuceJ.M., TurnerJ., VolberdingP. and HopewellP.C. (1986): Intensive care of patients with the acquired immunodeficiency syndrome. Outcome and changing patterns of utilization - Am. Rev. Respir. Dis. 134: 891–896.
WatcherR.M., RussiM.B., BlochD.A., HopewellP.C. and LuceJ.M. (1991): Pneumocystis carinii pneumonia and respiratory failure in AIDS. Improved outcomes and increased use of intensive care units - Am. Rev. Respir. Dis. 143: 251–256.
WhartonJ.M., ColemmanD.L., WofsyC.B., LuceJ.M., BlumenfeldW., HadleyW.K., Ingram-DrakeL., VolberdingP.A. and HopewellP.C. (1986): Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome - Ann. Intern. Med. 105: 37–44.
ZamanM.K. and WhiteD.A. (1988): Serum lactate dehydrogenase levels and Pneumocystis carinii pneumonia - Am. Rev. Respir. Dis. 137: 796–800.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Antinori, A., Maiuro, G., Pallavicini, F. et al. Prognostic factors of early fatal outcome and long-term survival in patients with Pneumocystis carinii pneumonia and acquired immunodeficiency syndrome. Eur J Epidemiol 9, 183–189 (1993). https://doi.org/10.1007/BF00158789
Issue Date:
DOI: https://doi.org/10.1007/BF00158789